BABBAN LABARI GA CHUANGKUN BIOTECH A KASUSUWA KEJEN SHANGHAI CHUANGKUN BIOTECH TB/NTM-DNA DETECTION KIT(LYOPHILIZED) TA THAILAND FDA TA YARDA!

A rana ta 1, Februray, Shanghai Chuangkun Biotechnology Co., Ltd. ta sami takardar shaidar rajista ta biyu na FDA ta Thailand don kayan gano tarin fuka/NTM-DNA, wanda aka yi amfani da na'urar gano PCV nau'i 15 na PCR wata daya da ya wuce.wanda ya bayyana cewa kayayyakin Chuangkun Biotech sun samu izini daga kasar Thailand FDA, da inganta kayayyakin da suka ɓullo da kansu, da kuma ba da tallafi mai ƙarfi ga Chuangkun Biotech don ƙara faɗaɗa kasuwannin duniya.

Kimanin mutane miliyan 10.6 a duniya sun kamu da cutar tarin fuka da WHO ta buga a shekarar 2021. Yawan karuwar da kashi 4.5 cikin dari fiye da na shekarar 2020. Yayin da mutane miliyan 1.6 suka mutu sakamakon tarin fuka a bara (ciki har da 6.7% na cikin masu dauke da cutar HIV) .A geographically, yawancin cututtukan tarin fuka a cikin 2021 sun kasance a cikin yankunan WHO na Kudu maso Gabas Asia (45%), Afirka (23%) da Yammacin Pacific (18%), tare da ƙananan hannun jari a Gabashin Bahar Rum (8.1%), Amurka. (2.9%) da Turai (2.2%).Yin la'akari da Cutar ta COVID-19, rigakafin cutar tarin fuka da sarrafawa yana ƙara yin tsauri ga Shirin Kawo Cutar Tarin Fuka na WHO.

Kayan aikin gano TB/NTM-DNA don CHUANGKUN Biotech an ƙirƙira shi ta hanyar hanyar lyophilization Tsarin zai magance rashin amfanin sufuri na dogon lokaci don kayan gano PCR na gargajiya, kuma yana kawo daidaito mai kyau da takamaiman sakamako sama da dacewa don amfani.

Shanghai Chuangkun Biotechnology Co., Ltd. ya sami takardar shaidar rajista ta biyu na FDA ta Thailand don kayan gano TB/NTM-DNA, yana nuna amincewa da FDA ta Thailand.Chuangkun Biotech za ta fashe a cikin rigakafin cutar tarin fuka na yanki da sarrafa karfi.